Skip to main content

Press Releases and Ad-hoc Announcements

28 October 2021
PR: Heidelberg Pharma Participates at Various Conferences
PDF
07 October 2021
PR: Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2021
PDF
01 October 2021
PR: Heidelberg Pharma AG Announces Adjustment of Guidance
PDF
09 September 2021
PR: Heidelberg Pharma Announces Presentation at H.C. Wainwright 23rd Annual Global Investment Conference and Participation at Various Conferences
PDF
07 September 2021
PR: Heidelberg Pharma Provides Update on Phase I/IIa Clinical Trial with ATAC Candidate HDP-101 in the US
PDF
19 July 2021
PR: Paul Ehrlich Institute Allows Heidelberg Pharma to Start a Phase I/IIa Clinical Trial with ATAC Candidate HDP-101
PDF
08 July 2021
PR: Heidelberg Pharma Reports on First Half-Year 2021
PDF
17 June 2021
PR: Heidelberg Pharma Announces Participation at Various Conferences
PDF
15 June 2021
Heidelberg Pharma AG Raises EUR 20 Million From Private Placement
PDF
15 June 2021
AH: Heidelberg Pharma AG to Raise Capital in a Private Placement
PDF
18 May 2021
PM: Annual General Meeting 2021 of Heidelberg Pharma Approves All Proposed Resolutions
PDF
29 April 2021
PR: Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2021
PDF
31 March 2021
PR: Heidelberg Pharma to Present New Data on its Proprietary ATAC Technology Platform at the AACR Annual Meeting 2021
PDF
25 March 2021
PR: Heidelberg Pharma announces financial figures for fiscal year 2020 and provides business update
PDF
19 March 2021
AH: Heidelberg Pharma AG Secures Financing Commitment From its Main Shareholder dievini
PDF
01 March 2021
PR: Heidelberg Pharma Expands Management Team
PDF
11 February 2021
PR: Heidelberg Pharma and Indiana University Publish Results on HER2-ATAC for Targeted Immunotherapy of Triple Negative Breast Cancer in Science Translational Medicine
PDF
04 February 2021
AH: FDA Allows Heidelberg Pharma to Start a Phase I/IIa Clinical Trial with ATAC Candidate HDP-101
PDF
21 December 2020
AH: Heidelberg Pharma AG Receives Shareholder Loan Based on an Existing Financing Commitment
PDF
12 November 2020
PR: Heidelberg Pharma will Present at German Equity Forum and Provides Update on Partner Activities for its Legacy Assets
PDF
05 November 2020
PR: Heidelberg Pharma Announces Several Presentations of Research Results on ATAC Technology at the ASH Annual Meeting 2020
PDF
08 October 2020
PR: Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2020
PDF
29 September 2020
AH: Heidelberg Pharma AG Announces Adjustment of Guidance
PDF
14 September 2020
PR: Heidelberg Pharma Receives Milestone Payment from Partner Magenta
PDF
10 September 2020
PR: Heidelberg Pharma Announces Participation at Various Conferences
PDF
22 July 2020
PR: Annual General Meeting 2020 of Heidelberg Pharma Approves All Proposed Resolutions
PDF
21 July 2020
AH: Heidelberg Pharma AG: Main Shareholder dievini Commits to Further Financing for Expansion of Proprietary Pipeline
PDF
09 July 2020
PR: Heidelberg Pharma reports on first half-year 2020
PDF
24 June 2020
PR: Heidelberg Pharma to Present at the Upcoming Virtual European Biotech Investor Day 2020
PDF
27 April 2020
AH: Heidelberg Pharma AG Plans Capital Increase to Fund Its ATAC Development Program
PDF